Grace Therapeutics Statistics
NASDAQ: GRCEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.02-0.08 (-3.79%)
Market open · Delayed 15 min · as of Oct 8, 11:17 AM ET
Grace Therapeutics by the numbers
Grace Therapeutics has a market capitalization of $42.5 million based on 21.04M shares outstanding. With trailing EPS of $-1.17, Grace Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.3% below its 50-day average and 31.6% below its 200-day average.
Average daily trading volume is 171.87K shares, or about $347,183 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GRCE valuation vs. peer median
| Metric | GRCE | Peer median | Difference |
|---|---|---|---|
| Market cap | $42.49M | $43.79M | -3% |
| Avg. volume | 171.87K | 313.86K | -45% |
Peer median across 8 companies: NSRX, SCYX, HOWL, CPHI, VERU, ELTX, CELU, IXHL.
Valuation
- Market cap
- $42.49M
- EPS (TTM)
- $-1.17
- Shares outstanding
- 21.04M
Price and trading
- Previous close
- 2.10
- Open
- 2.05
- Day range
- 2.00 – 2.07
- 52-week range
- 1.79 – 5.18
- 52-week change
- -30.46%
- Beta
- —
- Volume
- 16.04K
- Average volume
- 171.87K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jun 20, 2025
Additional statistics
- Market Cap
- 42.49M
- Forward Pe
- -4.49
- Eps
- -1.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.18
- Week52 Low
- 1.79
- Avg Volume
- 171.87K
- Shares Outstanding
- 21.04M
- Ma50
- 2.13
- Ma200
- 2.95
- Earnings Date
- Jun 20, 2025
- Pct From52w High
- -61.00%
- Pct From52w Low
- 12.85%